Andere Sprachen Destiny Pharma plc

Aktien

A2DW69

GB00BDHSP575

DEST

Markt geschlossen - London S.E. Andere Börsenplätze 17:35:15 30.04.2024			% 5 Tage	% 1. Jan.
17.75 ^GBX	+1.43%		-22.83%	-74.64%

25.04.	Norcros veräußert Johnson Tiles UK; Trifast entwickelt sich gut	AN
25.04.	Transcript : Destiny Pharma plc, 2023 Earnings Call, Apr 25, 2024

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Norcros sells Johnson Tiles UK; Trifast trading well	25.04.
AIM WINNERS & LOSERS: Kromek jumps 14% on US government contract	25.04.
Destiny Pharma plc Reports Earnings Results for the Full Year Ended December 31, 2023	25.04.
EARNINGS AND TRADING: STV raises holding in Two Cities Television	31.01.
Destiny Pharma to Advance Skin, Colon Infection Therapies After Positive Evaluations	31.01.
Destiny Pharma plc Announces Clinical Development Update Positive Results from XF-73 Dermal Safety Study	31.01.
Destiny Pharma seeks to capitalise on XF-73 market potential in 2024	04.01.
Destiny Pharma Says Talks Ongoing with Potential Partners for Nasal Asset	04.01.
Destiny Pharma celebrates study findings on "potent" flagship drug	17.10.23
AIM WINNERS & LOSERS: Destiny Pharma posts "landmark" XF-73 data	17.10.23
Destiny Pharma plc Announces the Publication of New Microbiological Data on Xf-73 (Exeporfinium Chloride), Its Leading Antibacterial Drug,In Frontiers in Cellular and Infection Microbiology	17.10.23
Dianomi swings to loss; Epwin revenue up	20.09.23
Destiny Pharma : Interim results for the six months ended 30 June 2023	20.09.23
Earnings Flash (DEST.L) DESTINY PHARMA Reports H1 Loss GBX-3.10	20.09.23
Destiny Pharma plc Reports Earnings Results for the Half Year Ended June 30, 2023	20.09.23
MGC Pharmaceuticals granted psilocybin import permit	31.07.23
Destiny Pharma plc Announces the Publication of New Data in the Journal Infection & Drug Resistance from A Study Evaluating the Pfficacy of Xf-73	31.07.23
FTSE 100 Closes Tuesday Up 0.2% Lifted by Unilever, Miners	25.07.23
Destiny Pharma says former Chair Nigel Rudd return to role	25.07.23
Former Destiny Pharma Chairman Reprises Role	25.07.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Destiny Pharma plc

Aktien

A2DW69

GB00BDHSP575

DEST

Andere Sprachen

Filter